Clinical Trials Logo

Colorectal Cancer Metastatic clinical trials

View clinical trials related to Colorectal Cancer Metastatic.

Filter by:

NCT ID: NCT02149784 Recruiting - Clinical trials for Colorectal Cancer Metastatic

Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients

Start date: September 2015
Phase: Phase 3
Study type: Interventional

There is still no perfect treatment suggestion for patients with asymptomatic colorectal cancer with unresectable metastatic disease. Whether patients can benefit from palliative resection of primary tumor or not is still waiting for answer. The investigators hypothesis that asymptomatic metastatic colorectal cancer patients who respond to chemotherapy will benefit from primary tumor resection.

NCT ID: NCT01959061 Recruiting - Clinical trials for Colorectal Cancer Metastatic

Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

TACE
Start date: September 2013
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of Raltitrexed for advanced colorectal cancer

NCT ID: NCT01249638 Recruiting - Clinical trials for Colorectal Cancer Metastatic

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Start date: December 2010
Phase: Phase 3
Study type: Interventional

Patient with multiple metastases, not eligible for surgery, might not profit from intensive chemotherapy regimens. Therefore less intensive regimens focusing on survival and disease control may be a better choice for first line treatment. Therefore this study investigates the combination of capecitabine and bevacizumab versus the combination of capecitabine, bevacizumab and irinotecan. In case of progressive disease, the therapy in patients treated with capecitabine and bevacizumab is intensified by adding irinotecan. Primary endpoint is time-of-failure strategy (TFS) comparing both treatment arms.